Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erdheim-Chester disease].

Paola Caramaschi1, Domenico Biasi, Maurizio Lestani

  • 1Dipartimento di Medicina Clinica e Sperimentale, Università, Verona.

Recenti Progressi in Medicina
|April 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Comparative analysis of drug therapy for fibrotic interstitial lung diseases based on results of phase 3 study].

Pneumologie (Stuttgart, Germany)·2026
Same author

Advances in Sarcoidosis.

Archivos de bronconeumologia·2026
Same author

KL-6 as a Biomarker for Adult Patients with Cystic Fibrosis and the Impact of <i>MUC1</i> Genotype.

Journal of clinical medicine·2026
Same author

Olive Oil and the Impact of Gastrointestinal Adverse Events During Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis: A Post-hoc Analysis of the MADIET Trial.

Archivos de bronconeumologia·2026
Same author

Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis (SSc), with and without interstitial lung disease (ILD).

BMJ open respiratory research·2026
Same author

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Frontiers in pharmacology·2026

Erdheim-Chester disease is a rare, neoplastic histiocytosis characterized by lipid-laden cells. Increased awareness is crucial for diagnosis, as it is often underrecognized in medical literature.

Area of Science:

  • Histiocytosis
  • Rare systemic disorders
  • Neoplastic pathology

Context:

  • Erdheim-Chester disease (ECD) is a rare systemic disorder of unknown etiology.
  • Characterized by xantogranulomatous infiltrates of foamy, lipid-laden histiocytes.
  • Involves multiple organs including bone, retroperitoneum, lung, pleura, pericardium, retroorbital tissue, brain, and major arteries.

Purpose:

  • To review the principal features of Erdheim-Chester disease.
  • To highlight its distinction from Langerhans' cell histiocytosis.
  • To emphasize the need for greater awareness and recognition.

Summary:

  • Erdheim-Chester disease presents with diverse clinical manifestations and variable courses.
  • Histologically, it features xantogranulomatous infiltrates of lipid-laden histiocytes.

Related Experiment Videos

  • It differs from Langerhans' cell histiocytosis in clinical, histologic, and immunohistochemical aspects.

    • Impact:

    • Suggests Erdheim-Chester disease may be more frequent than currently diagnosed.
    • Underscores the diagnostic challenges due to limited awareness and reporting in medical texts.
    • Aims to improve recognition and diagnosis of this rare condition.